Trial intelligence / Profile preview

DETECT: Treatments for Dupuytren's Contracture

NCT03192020Phase 4Active, not recruiting

Sponsor
Tampere University
Start
Sep 2017
Primary completion
May 2026
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Tampere University. Started Sep 2017; status: active, not recruiting.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on NCT03192020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03192020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call